Literature DB >> 17965021

The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival.

Fang-Tsyr Lin1, Yun-Ju Lai, Natalia Makarova, Gabor Tigyi, Weei-Chin Lin.   

Abstract

Lysophosphatidic acid (LPA) promotes cell survival through the activation of G protein-coupled LPA receptors. However, whether different LPA receptors activate distinct anti-apoptotic signaling pathways is not yet clear. Here we report a novel mechanism by which the LPA(2) receptor targets the proapoptotic Siva-1 protein for LPA-dependent degradation, thereby attenuating Siva-1 function in DNA damage response. The carboxyl-terminal tail of the LPA(2) receptor, but not LPA(1) or LPA(3) receptor, specifically associates with the carboxyl cysteine-rich domain of Siva-1. Prolonged LPA stimulation promotes the association of Siva-1 with the LPA(2) receptor and targets both proteins for ubiquitination and degradation. As a result, adriamycin-induced Siva-1 protein stabilization is attenuated by LPA in an LPA(2)-dependent manner, and the function of Siva-1 in promoting DNA damage-induced apoptosis is inhibited by LPA pretreatment. Consistent with this result, inhibition of the LPA(2) receptor expression increases Siva-1 protein levels and augments adriamycin-induced caspase-3 cleavage and apoptosis. Together, these findings reveal a critical and specific role for the LPA(2) receptor through which LPA directly inactivates a critical component of the death machinery to promote cell survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965021      PMCID: PMC3496872          DOI: 10.1074/jbc.M705025200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome.

Authors:  U E Petaja-Repo; M Hogue; A Laperriere; S Bhalla; P Walker; M Bouvier
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

2.  Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting.

Authors:  A Marchese; J L Benovic
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

3.  The ARG tyrosine kinase interacts with Siva-1 in the apoptotic response to oxidative stress.

Authors:  C Cao; X Ren; S Kharbanda; A J Koleske; A Koleske; K V Prasad; D Kufe
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

4.  Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry.

Authors:  D L Baker; D M Desiderio; D D Miller; B Tolley; G J Tigyi
Journal:  Anal Biochem       Date:  2001-05-15       Impact factor: 3.365

5.  Murine Siva-1 and Siva-2, alternate splice forms of the mouse Siva gene, both bind to CD27 but differentially transduce apoptosis.

Authors:  Y Yoon; Z Ao; Y Cheng; S F Schlossman; K V Prasad
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

6.  Gene expression profiling by cDNA array in human hepatoma cell line in response to cisplatin treatment.

Authors:  Lan F Qin; Terence K W Lee; Irene O L Ng
Journal:  Life Sci       Date:  2002-02-22       Impact factor: 5.037

7.  Siva-1 binds to and inhibits BCL-X(L)-mediated protection against UV radiation-induced apoptosis.

Authors:  Li Xue; Fei Chu; Yuan Cheng; Xiangjie Sun; Alip Borthakur; Manjunath Ramarao; Pramod Pandey; Mei Wu; Stuart F Schlossman; Kanteti V S Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

8.  Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase.

Authors:  X Fang; S Yu; R LaPushin; Y Lu; T Furui; L Z Penn; D Stokoe; J R Erickson; R C Bast; G B Mills
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

9.  TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes.

Authors:  H Xiao; V Palhan; Y Yang; R G Roeder
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

10.  Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.

Authors:  S K Shenoy; P H McDonald; T A Kohout; R J Lefkowitz
Journal:  Science       Date:  2001-10-04       Impact factor: 47.728

View more
  38 in total

Review 1.  Multifaceted functions of Siva-1: more than an Indian God of Destruction.

Authors:  Yide Mei; Mian Wu
Journal:  Protein Cell       Date:  2012-03-17       Impact factor: 14.870

Review 2.  Ubiquitination of G protein-coupled receptors: functional implications and drug discovery.

Authors:  Michael R Dores; JoAnn Trejo
Journal:  Mol Pharmacol       Date:  2012-06-14       Impact factor: 4.436

3.  p53 target Siva regulates apoptosis in ischemic kidneys.

Authors:  Kurinji Singaravelu; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-09

4.  The LPA2 receptor agonist Radioprotectin-1 spares Lgr5-positive intestinal stem cells from radiation injury in murine enteroids.

Authors:  Bryan Kuo; Erzsébet Szabó; Sue Chin Lee; Andrea Balogh; Derek Norman; Asuka Inoue; Yuki Ono; Junken Aoki; Gábor Tigyi
Journal:  Cell Signal       Date:  2018-07-29       Impact factor: 4.315

5.  Thromboxane A2 modulates cisplatin-induced apoptosis through a Siva1-dependent mechanism.

Authors:  C Iorio-Morin; P Germain; S Roy; S Génier; P Labrecque; J-L Parent
Journal:  Cell Death Differ       Date:  2012-02-17       Impact factor: 15.828

Review 6.  Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Authors:  Gabor J Tigyi; Leonard R Johnson; Sue Chin Lee; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Karin Thompson; Alyssa Boler; W Shannon McCool
Journal:  J Lipid Res       Date:  2019-01-28       Impact factor: 5.922

7.  Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.

Authors:  Shuyu E; Yun-Ju Lai; Ryoko Tsukahara; Chen-Shan Chen; Yuko Fujiwara; Junming Yue; Jei-Hwa Yu; Huazhang Guo; Akio Kihara; Gábor Tigyi; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

Review 8.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

9.  Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions.

Authors:  Gyöngyi N Kiss; James I Fells; Renuka Gupte; Sue-Chin Lee; Jianxiong Liu; Nóra Nusser; Keng G Lim; Ramesh M Ray; Fang-Tsyr Lin; Abby L Parrill; Balázs Sümegi; Duane D Miller; Gabor Tigyi
Journal:  Mol Pharmacol       Date:  2012-09-11       Impact factor: 4.436

10.  TRIP6 regulates p27 KIP1 to promote tumorigenesis.

Authors:  Victor T G Lin; Vivian Y Lin; Yun-Ju Lai; Chen-Shan Chen; Kang Liu; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  Mol Cell Biol       Date:  2013-01-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.